Globus Medical, Inc.
Moat Score — Globus Medical, Inc.
Total Moat Score
17 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 5 / 5 | Globus holds 3,374 issued U.S. patents and 2,311 foreign patents across implants, biologics, and robotics, and FDA clearances for its ExcelsiusGPS platform and broad implant portfolio create meaningful regulatory and IP barriers to direct replication. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 2 / 5 | The NuVasive and Nevro combinations added manufacturing and salesforce scale, but Globus still operates at a fraction of the scale of giants like Medtronic, Stryker, and J&J's DePuy Synthes, limiting any structural cost edge. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 3 / 5 | Capital equipment like ExcelsiusGPS commands premium pricing once a hospital commits to the platform, and implant pricing benefits from surgeon familiarity and procedural outcomes data, though large competitors and hospital purchasing power constrain pricing broadly. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 1 / 5 | There is no meaningful network effect in implant or robotics sales; one hospital's adoption of ExcelsiusGPS does not directly increase the platform's value to another hospital, beyond modest surgeon-training and data-accumulation benefits. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 4 / 5 | Once a hospital has installed ExcelsiusGPS and trained surgeons and staff on its workflow, switching to a competing robotics platform involves real retraining, revalidation, and workflow disruption, anchoring recurring implant and instrument sales. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 2 / 5 | Spine and orthopedic device manufacturing requires significant capital and regulatory investment, but the market still supports numerous well-funded competitors (Medtronic, Stryker, Zimmer Biomet, Alphatec, Orthofix), so efficient-scale protection is only moderate. |